The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes-Reference-Cited by-同舟云学术

The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes

Published:2016-03-30 Issue:1 Volume:280 Page:24-38
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Rider L. G.¹,Nistala K.²

Affiliation:

1. Environmental Autoimmunity Group; Clinical Research Branch; National Institute of Environmental Health Sciences; National Institutes of Health; Bethesda MD USA

2. Centre for Rheumatology; University College London; London UK

Funder

National Institutes of Health

National Institute of Environmental Health Sciences

JM Foundation

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12444/fullpdf

Reference96 articles.

1. Polymyositis and dermatomyositis. Parts 1 and 2;Bohan;N Engl J Med,1975

2. Progress report on development of classification criteria for adult and juvenile idiopathic inflammatory myopathies;Tjärnlund;Arthritis Rheum,2012

3. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies;Rider;Rheum Dis Clin North Am,2013

4. A58: demographics, clinical features and therapies of patients with juvenile dermatomyositis participating in a national myositis patient registry;Rider;Arthritis Rheumatol,2014

5. Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research;Rider;Curr Opin Rheumatol,2014

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies;Seminars in Arthritis and Rheumatism;2024-10

2. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review;Children;2024-08-27

3. Clinical and genetic analysis of macrophage activation syndrome complicating juvenile idiopathic inflammatory myopathies;Pediatric Research;2024-08-24

4. Childhood Arthritis and Rheumatology Research Alliance Biologic Disease‐Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis;Arthritis Care & Research;2024-08-14

5. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry;Pediatric Rheumatology;2024-07-22